Net Debt Summary of BioCorRx Inc.

BioCorRx Inc.'s latest annual net debt in 2023 was 5.56 Million USD , up 246.12% from previous year.
BioCorRx Inc.'s latest quarterly net debt in 2024 Q1 was 6.02 Million USD , up 8.15% from previous quarter.
BioCorRx Inc. reported annual net debt of 1.6 Million USD in 2022, up 2.7% from previous year.
BioCorRx Inc. reported annual net debt of 1.56 Million USD in 2021, up 331.02% from previous year.
BioCorRx Inc. reported quarterly net debt of 6.02 Million USD for 2024 Q1, up 8.15% from previous quarter.
BioCorRx Inc. reported quarterly net debt of 1.69 Million USD for 2023 Q1, up 5.12% from previous quarter.

Annual Net Debt Chart of BioCorRx Inc. (2023 - 2008)

Historical Annual Net Debt of BioCorRx Inc. (2023 - 2008)

Year	Net Debt	Net Debt Growth
2023	5.56 Million USD	246.12%
2022	1.6 Million USD	2.7%
2021	1.56 Million USD	331.02%
2020	363.53 Thousand USD	119.87%
2019	-1.82 Million USD	-144.8%
2018	4.08 Million USD	86.34%
2017	2.19 Million USD	105.39%
2016	1.06 Million USD	-30.61%
2015	1.53 Million USD	116.0%
2014	711.81 Thousand USD	-8.12%
2013	774.69 Thousand USD	711.69%
2012	95.44 Thousand USD	-49.83%
2011	190.23 Thousand USD	10294.8%
2010	-1866.00 USD	65.29%
2009	-5376.00 USD	-78.25%
2008	-3016.00 USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	6.2 Million USD	-64.35%
2024 Q1	6.02 Million USD	8.15%
2023 Q1	1.69 Million USD	5.12%
2023 Q3	1.48 Million USD	7.9%
2023 FY	5.56 Million USD	246.12%
2023 Q4	5.56 Million USD	275.62%
2023 Q2	1.37 Million USD	-18.76%
2022 Q1	4.39 Million USD	180.42%
2022 Q3	1.28 Million USD	-14.81%
2022 Q2	1.51 Million USD	-65.57%
2022 FY	1.6 Million USD	2.7%
2022 Q4	1.6 Million USD	24.86%
2021 FY	1.56 Million USD	331.02%
2021 Q4	1.56 Million USD	67.54%
2021 Q3	935.24 Thousand USD	207.42%
2021 Q2	304.22 Thousand USD	130.18%
2021 Q1	-1 Million USD	-377.26%
2020 Q2	-651.79 Thousand USD	44.42%
2020 Q3	44.15 Thousand USD	106.77%
2020 FY	363.53 Thousand USD	119.87%
2020 Q4	363.53 Thousand USD	723.38%
2020 Q1	-1.17 Million USD	35.89%
2019 Q1	4.77 Million USD	16.87%
2019 Q4	-1.82 Million USD	38.74%
2019 Q3	-2.98 Million USD	-970.87%
2019 Q2	342.82 Thousand USD	-92.82%
2019 FY	-1.82 Million USD	-144.8%
2018 Q4	4.08 Million USD	22.99%
2018 Q2	2.6 Million USD	-6.84%
2018 Q1	2.8 Million USD	27.83%
2018 FY	4.08 Million USD	86.34%
2018 Q3	3.31 Million USD	27.22%
2017 Q2	607.16 Thousand USD	205.34%
2017 Q3	1.54 Million USD	154.28%
2017 Q4	2.19 Million USD	41.93%
2017 FY	2.19 Million USD	105.39%
2017 Q1	-576.38 Thousand USD	-154.03%
2016 Q2	-124.79 Thousand USD	-113.31%
2016 Q3	804.07 Thousand USD	744.32%
2016 FY	1.06 Million USD	-30.61%
2016 Q4	1.06 Million USD	32.68%
2016 Q1	937.89 Thousand USD	-39.0%
2015 Q1	742.75 Thousand USD	4.35%
2015 Q2	1.64 Million USD	121.62%
2015 Q3	1.79 Million USD	8.82%
2015 Q4	1.53 Million USD	-14.17%
2015 FY	1.53 Million USD	116.0%
2014 Q2	263.59 Thousand USD	-67.85%
2014 Q1	819.9 Thousand USD	5.84%
2014 Q3	757.02 Thousand USD	187.19%
2014 Q4	711.81 Thousand USD	-5.97%
2014 FY	711.81 Thousand USD	-8.12%
2013 Q1	308.32 Thousand USD	223.05%
2013 Q3	299.76 Thousand USD	-52.27%
2013 Q4	774.69 Thousand USD	158.43%
2013 FY	774.69 Thousand USD	711.69%
2013 Q2	628.09 Thousand USD	103.71%
2012 Q2	136.57 Thousand USD	-37.36%
2012 FY	95.44 Thousand USD	-49.83%
2012 Q4	95.44 Thousand USD	-59.12%
2012 Q1	218.03 Thousand USD	14.61%
2012 Q3	233.44 Thousand USD	70.93%
2011 Q1	8884.00 USD	576.1%
2011 Q3	15.19 Thousand USD	0.0%
2011 Q2	15.19 Thousand USD	71.06%
2011 FY	190.23 Thousand USD	10294.8%
2011 Q4	190.23 Thousand USD	1151.79%
2010 Q1	-2642.00 USD	50.86%
2010 Q3	-9050.00 USD	-11502.56%
2010 Q4	-1866.00 USD	79.38%
2010 FY	-1866.00 USD	65.29%
2010 Q2	-78.00 USD	97.05%
2009 Q2	-301.00 USD	89.1%
2009 Q1	-2761.00 USD	8.45%
2009 FY	-5376.00 USD	-78.25%
2009 Q4	-5376.00 USD	-2522.44%
2009 Q3	-205.00 USD	31.89%
2008 FY	-3016.00 USD	0.0%
2008 Q1	-2661.00 USD	0.0%
2008 Q4	-3016.00 USD	-56.27%
2008 Q3	-1930.00 USD	0.0%

Peer Net Debt Comparison of BioCorRx Inc.

Name	Net Debt	Net Debt Difference
The Amacore Group, Inc.	-469.62 Thousand USD	1285.94%
Arem Pacific Corporation	181.02 Thousand USD	-2976.684%
Assisted 4 Living, Inc.	-199.71 Thousand USD	2888.768%
Bionik Laboratories Corp.	1.98 Million USD	-180.59%
Banyan Corp.	3.6 Million USD	-54.427%
Clearday, Inc.	44.86 Million USD	87.587%
Dental Patient Care America, Inc.	-1.99 Million USD	378.894%
Quantum Medical Transport, Inc.	1065.27 USD	-522725.669%
Empower Clinics Inc.	2.29 Million USD	-142.274%
First Choice Healthcare Solutions, Inc.	23.22 Million USD	76.024%
Selectis Health, Inc.	35.76 Million USD	84.426%
Ethema Health Corporation	14.51 Million USD	61.628%
HealthLynked Corp.	1.72 Million USD	-222.586%
HQDA Elderly Life Network Corp.	- USD	-Infinity%
Healthcare Solutions Management Group, Inc.	13.79 Million USD	59.622%
JRSIS Health Care Corporation	911.83 Thousand USD	-510.803%
Comjoyful International Company	-28.32 Thousand USD	19760.083%
Medical Facilities Corporation	92.22 Million USD	93.961%
MedSmart Group Inc.	659.56 Thousand USD	-744.426%
North America Frac Sand, Inc.	265.41 Thousand USD	-1998.414%
Nova Leap Health Corp.	-686.52 Thousand USD	911.259%
Nexteligent Holdings, Inc.	1.83 Million USD	-202.978%
PAO Group, Inc.	639.37 Thousand USD	-771.086%
Primemd Inc.	4.54 Million USD	-22.579%
Raffles Medical Group Ltd	-194.49 Million USD	102.864%
Ryman Healthcare Limited	1.51 Billion USD	99.631%
Stem Cell Authority, Ltd.	15.00 USD	-37129933.333%
SETO Holdings, Inc.	- USD	-Infinity%
Optima Medical Innovations Corp.	1.24 Million USD	-348.026%
Mycotopia Therapies, Inc.	811.51 Thousand USD	-586.308%
U.S. NeuroSurgical Holdings, Inc.	-381 Thousand USD	1561.812%
Veltex Corporation	2.17 Million USD	-155.55%
World Financial Holding Group	98.11 Thousand USD	-5576.623%
Xcelerate Inc.	1.18 Million USD	-370.889%

Global Stocks Search

BioCorRx Inc. (BICX)

Net Debt Summary of BioCorRx Inc.

Annual Net Debt Chart of BioCorRx Inc. (2023 - 2008)

Historical Annual Net Debt of BioCorRx Inc. (2023 - 2008)

Peer Net Debt Comparison of BioCorRx Inc.